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ABSTRACT
Objective: The present study involves the analysis of mecA gene mediated antibiotic resistance in Staphylococcus aureus and screening for potential 
ligands.
Methods: Swab samples of patients with foot ulcers were collected from hospitals in and around Chennai. The samples were collected in sterile 
containers containing Enriched Thioglycollate broth transport media and transported to the laboratory within two hours of collection and processed.
Results: The results indicate the interaction capacity of Rosmaric acid with Penicillin binding protein. The 2D interaction results indicate the 
information about non bonded interactions of ligand and receptor. Best interaction was obtained with Rosmaric acid with a score of 41.16 and 5 
h-bond interactions were obtained.  The Molecular docking results indicates the interaction of the inhibitors to the antibiotic resistant proteins with 
a positive fitness.
Conclusion: From the current study, molecular docking approach has proved to be an efficient method for the identification of novel lead compounds 
against β-lactam resistant S. aureus from a broad spectrum of plant compounds and among the studied inhibitors rosmarinic acid was found to be a 
potent lead molecule.
Keywords: Mec A, PBP (penicillin binding protein), Docking.
INTRODUCTION
Staphylococcus aureus is a common nosocomial pathogen. 
Staphylococcal infection markedly increases the morbidity and 
mortality in hospitalized patients [1]. The organism has emerged 
as one of the important and major threat to human community due 
to rise in antibiotic resistance [2]. Multi-drug resistance in bacteria 
is usually conferred by enzymes encoded from chromosomal or 
extrachromosomal genes [3]. Staphylococcus causes frequent infections 
on prosthetic devices, osteomyelitis, and endocarditis [4]. Multi 
resistance has become a common feature in S. aureus [5]. Methicillin-
resistant S. aureus (MRSA) has now emerged as a widespread cause 
of community infections. The growing problem in the Indian scenario 
is that MRSA prevalence has increased from 12% in 1992 to 80.83% 
in 1999 [6]. It is responsible for a wide spectrum of infections and 
has a remarkable genetic versatility which allows them for the 
adaptation to multiple antibiotics. Most of the S. aureus isolates are 
found to be resistant to antibiotics [7] and it has been classified as one 
of the major public health threats of the 21st century [8]. Therefore, 
antibiotic options in the treatment against these organisms are 
extremely limited.
Bacterial membrane protein plays an important role in growth, cell 
division and maintaining the cellular structure of bacteria. These 
proteins are major drug targets for controlling the pathogen. Two 
mechanisms have been reported to be responsible for antibiotic 
resistance: Structural modification in penicillin-binding protein 
(PBP) targets and production of β-lactamase [9]. β-lactam antibiotics 
(penicillin, cephalosporins, carbapenems, and monobactams) target 
PBP, which are responsible for bacterial cell wall synthesis [10]. It is 
observed that the resistances shown by S. aureus have been increasing 
to most of the β-lactam antibiotics [11-13]. The broad-spectrum 
beta-lactam resistance in MRSA strains is due to the presence of 
PBP [14]. In both Gram-positive and Gram-negative bacteria, PBP is 
viewed as an attractive target for the development of antimicrobial 
compounds [13,15]. Therefore, the more research in this field is 
required to identify new therapeutic agents for controlling infections 
caused by S. aureus. Hence, this study focuses on finding lead compound 
against PBP in S. aureus by performing molecular docking studies 
against 11 active compounds from 5 medicinal plants.
METHODS
Homology modeling
A homology model was built for PBP of S. aureus using MODELLER 9.10 
(http://salilab.org/modeller/modeller.html). The three-dimensional 
(3D) structure of PBP from Staphylococcus sp. (PDB ID: 1VQQ) was used 
as the structural homolog to build the model. The “align2d.py” program 
has been employed to perform an alignment between the target and 
template sequence. The rough 3D model was generated using the 
“model-default.py” program. The rough model was subjected to loop 
refining using “loop.py” program. The quality of the obtained model 
was verified using the PROCHEK server (http://nihserver.mbi.ucla.
edu/SAVES/).
Active site prediction
The possible binding site of PBP was determined using Q site finder 
(http//bmbpcu36.leeds.ac.uk/qsitefinder). The obtained binding 
site for PBP from Q site finder was compared to the active sites of the 
template to determine the residues forming the binding pocket.
Ligand preparation
About 11 compounds with antimicrobial property from Azadirachta 
indica, Curcuma longa, Cuminum cyminum, Terminalia chebula, and 
Mentha spicata (Table 1) were derived from Dr. Duke’s Phytochemical 
and Ethnobotanical Databases. The structures were retrieved using 
PUBCHEM database. The two-dimensional structures were drawn 
using ACD Chemsketch (www.acdlabs.com/). The structures were then 
converted to their 3D geometries, optimized and saved in “MDL mol 
file” format.
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GOLD docking simulations
Automated docking studies were performed using the genetic algorithm 
(GA) GOLD (Version 3.2 CCDC, Cambridge, UK) [16]. The algorithm 
had been previously validated and successfully tested on a data set of 
over 300 complexes extracted from the PDB [17]. Ligands rosmarinic 
acid rutin stigmasterol cuminaldehyde curcumin curlone ellagic-acid 
eugenol ketoprofen menthone and pectin were docked into the binding 
site of the receptor (PBP) using GOLD [18]. The GOLD program uses a 
GA to explore the full range of ligand conformational flexibility and the 
rotational flexibility of selected receptor hydrogen’s. Grid was prepared 
for the protein with the center and the size of the bounding box set on 
10 Å. The coordinates of the enclosing box (x=121 Å; y=87 Å; z=45 Å) 
were defined starting from the set of active site residues. During docking 
process, a maximum of 10 different conformations was considered for 
the drug. The conformer with the highest binding score was used for 
further analysis [19].
RESULTS AND DISCUSSION
The β-lactam antibiotics resistant natures of the most S. aureus strains 
found in hospitals symbolize a therapeutical challenge for treating 
serious MRSA infections. PBP is a key enzyme required for the cell 
wall synthesis of S. aureus. Inhibition of these proteins is important for 
controlling the pathogen.
The 3D structure of PBP, of S. aureus has been predicted (Fig. 1) and was 
subjected to validation using PROCHEK server [20].
The Ramachandran plot shows 84.5% of residues in the most favored 
region, 13.9% in additionally allowed region, 1.6% residues in 
generously allowed region and 0% residues in the disallowed region 
(Fig. 2). Thereby 0% of amino acid in the disallowed region indicates 
the overall stable conformation of the protein structure.
The inhibiting susceptibility of the compounds was evaluated using 
their fitness scores generated by the GOLD software. Ligand – receptor 
interactions were analyzed based on the binding compatibility of ligand 
in the active site of PBP (docked energy in kcal/mol [fitness]) [19].
Docking of PBP was performed with 11 potential inhibitors (Fig. 3). 
The final docked conformation for 11 ligands obtained after through 
docking analysis was evaluated based on the number of hydrogen bonds 
(H-bonds) formed and bond distance between atomic coordinates of 
the active site and inhibitor (Table 2).
The H-bond interactions between the 11 inhibitors and PBP along 
with their bond distances, amino acid involved, atom involved and 
their corresponding scores are described in Table 2. The inhibitor 
rosmarinic acid from mint binds with the receptor with the highest 
GOLD score of 41.16 (Fig. 4), comparatively the inhibitor ketoprofen 
from C. longa binds with a score of 39.4 (Fig. 5) and curcumin an active 
compound of C. longa also binds with a maximum score of 36.02 (Fig. 6) 
and followed by other inhibitors. Least score of 9.3 was obtained with 
Table 1: Molecular properties of plant derived compounds
S. No. Ligand Source Molecular weight Molecular formula H-bond donor H-bond acceptor
1 Rosmarinic acid M. spicata 360.31 C18H16O8 5 8
2 Rutin A. indica 610.51 C27H30O16 10 16
3 Stigmasterol C. longa 412.69 C29H48O 1 1
4 Cuminaldehyde C. cyminum 148.20 C10H12O 0 1
5 Curcumin C. longa 368.37 C21H20O6 2 6
6 Curlone C. longa 218.33 C15H22O 0 1
7 Ellagic-acid T. chebula 302.19 C14H6O8 4 8
8 Eugenol C. longa 164.20 C10H12O2 1 2
9 Ketoprofen C. longa 254.28 C16H14O3 1 3
10 Menthone M. spicata 154.24 C10H18O 0 1
11 Pectin T. chebula 194.13 C6H10O7 5 7
M. spicata: Mentha spicata, A. indica: Azadirachta indica, C. longa: Curcuma longa, C. cyminum: Cuminum cyminum, T. chebula: Terminalia chebula
Fig. 1: Tertiary structure of the penicillin-binding protein
Fig. 2: Three-dimensional structure validation of penicillin-
binding protein after loop refinement
vitamin E against the receptor. From the H-bond formations between 
the 11 inhibitors and the PBP it is evident that rosmarinic acid form five 
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H-bonds, inhibitor ketoprofen from one H-bonds and curcumin forms 
five H-bonds.
Although ketoprofen forms a higher interaction score when compared 
to curcumin from C. longa, h-bond interactions clearly indicate that 
curcumin forms a stable interaction than ketoprofen. Similarly, active 
molecules rutin of A. indica, pectin and ellagic-acid from T. chebula 
Fig. 3: Three-dimensional structures of rosmarinic acid, rutin, stigmasterol, cuminaldehyde, curcumin, curlone, ellagic-acid, eugenol, 
ketoprofen, menthone, and pectin
Table 2: Represents the fitness score and the H-bond 
interactions with ligands and penicillin-binding protein







Stigmasterol O25 Glu158:OE2 2.428 10.33
Cuminaldehyde 32.5
Ellagic-acid O9 Thr204:N 2.604 32.52
O11 Thr204:N 2.936
O20 Tyr184:OH 2.425
Menthone O7 Asp214:OD2 2.387 20.18
Pectin O7 Glu158:OE2 2.897 29.16
O8 Thr204:OG1 2.619
O13 Glu158:OE2 2.997
Ketoprofen O10 Ser213:OG 2.242 39.4





Rutin O28 Thr204:OG1 2.867 29.38
O29 Lys203:N 2.38
O29 Leu202:N 2.786
Vitamin E - - - 9.3





Fig. 4: Penicillin-binding protein of Staphylococcus aureus in 
complex with rosmarinic acid
Fig. 5: Penicillin-binding protein of Staphylococcus aureus in 
complex with ketoprofen
forms three H-bond with the receptor with a GOLD score of 29.38, 
29.16 and 32.52 respectively. The amino acid residues Thr204, Ser181, 
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Glu158, are involved in the interaction with rosmarinic acid. From the 
H-bond analysis is evident that amino acids GLU158, Thr204, Tyr184, 
Asp214, Ser213, Ser181, Lys203, Leu202 (Fig. 7) of the receptor are 
involved in H-bond formation with the 11 active molecules.
CONCLUSION
In recent years, many plants derived compounds are identified with 
antibacterial activity, but many aspects concerning their mechanisms 
of actions are still to be predicted. PBP are enzymes required for 
bacterial cell wall synthesis. Novel targets for PBP is required for 
the inhibition of bacteria. From the current study, molecular docking 
approach has proved to be an efficient method for the identification 
of novel lead compounds against β-lactam resistant S. aureus from a 
broad spectrum of plant compounds. 11 compounds were analyzed 
against PBP of which, rosmarinic acid showed high binding affinity 
against PBP. Hence, rosmarinic acid may be a potent lead molecule. 
It also assesses the various interactions of the drug target with its 
inhibitors thereby providing insight into the prospects of structure-
based drug design.
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Fig. 6: Penicillin-binding protein of Staphylococcus aureus in 
complex with curcumin
Fig. 7: Red region indicates the ligand binding site of penicillin-
binding protein
